Twin Capital Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Twin Capital Management's RMD Position: Q2 2026 in Review
Twin Capital Management reduced its ResMed (RMD) stake by 13% in Q2 2026, selling an estimated $98K and leaving 3,043 shares worth $593K. The position accounts for 0.06% of the portfolio, ranked #236.
Twin Capital Management first reported a position in RMD in Q2 2013 and has held it in 18 quarters since. The position peaked at $2.47M in Q3 2018. 888 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Twin Capital Management held 3,043 shares of ResMed worth $593K as of Q2 2026.
- Twin Capital Management sold 473 ResMed shares in Q2 2026, an estimated $98K.
- ResMed made up 0.06% of Twin Capital Management's portfolio in Q2 2026, its #236 holding.
- Twin Capital Management first reported a position in ResMed in Q2 2013 and has held it in 18 quarters since.
- Twin Capital Management's ResMed position peaked at $2.47M in Q3 2018.
- 888 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Twin Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.